Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay
Luca Koechlin,Jasper Boeddinghaus,Pedro Lopez-Ayala,Cornelia Reber,Thomas Nestelberger,Karin Wildi,Carlos C Spagnuolo,Ivo Strebel,Jonas Glaeser,Paolo Bima,Luca Crisanti,Lourdes Herraiz-Recuenco,Elisa Dubach,Òscar Miró,F Javier Martin-Sanchez,Damian Kawecki,Dagmar I Keller,Michael Christ,Andreas Buser,Maria Rubini Giménez,Gro Leite Størvold,Marianne Nordlund Broughton,Torbjørn Omland,Magnus N Lyngbakken,Helge Røsjø,Christian Mueller,APACE Investigators,Desiree Wussler,Christian Puelacher,Gabrielle Huré,Katharina Rentsch,Danielle M Gualandro,Julia Reinhardt,Ana Yufera Sanchez,Bernhard Okamura,Samyut Shrestha,Philip Haaf,Patrick Badertscher,Joan Elias Walter,Beatriz López,Gemma Martinez-Nadal,Esther Rodriguez Adrada,Jiri Parenica,Arnold von Eckardstein,Beata Morawiec,Piotr Muzyk,Henrik Schirmer
DOI: https://doi.org/10.1016/j.jacc.2024.05.056
2024-08-20
Abstract:Background: Point-of-care (POC) high-sensitivity cardiac troponin assays may further accelerate the diagnosis of myocardial infarction (MI). Objectives: This study sought to assess the clinical and analytical performance of the novel high-sensitivity cardiac troponin I (hs-cTnI)-SPINCHIP POC test. Methods: Adult patients presenting with acute chest discomfort to the emergency department were enrolled in an international, diagnostic, multicenter study. The final diagnosis was centrally adjudicated by 2 independent cardiologists using all clinical information. We compared the discriminatory performance of hs-cTnI-SPINCHIP with current established central laboratory assays and derived an assay-specific hs-cTnI-SPINCHIP 0/1-hour algorithm. Secondary analyses included sample type comparisons (whole blood, fresh/frozen plasma, and capillary finger prick) and precision analysis. Results: MI was the adjudicated final diagnosis in 214 (19%) of 1,102 patients. Area under the receiver-operating characteristic curve was 0.94 (95% CI: 0.92-0.95) for hs-cTnI-SPINCHIP vs 0.94 (95% CI: 0.92-0.95) for hs-cTnI-Architect (P = 0.907) and 0.93 (95% CI: 0.91-0.95) for high-sensitivity cardiac troponin T Elecsys (P = 0.305). A cutoff <7 ng/L at presentation (if chest pain onset was >3 hours) or <7 ng/L together with a 0/1-hour delta of <4 ng/L ruled out 51% with a sensitivity and negative predictive value of 100% (95% CI: 97.7%-100%) and 100% (95% CI: 99.0%-100%), respectively. A hs-cTnI-SPINCHIP concentration ≥36 ng/L or a 0/1-hour delta ≥11 ng/L ruled in 27% with a specificity and positive predictive value of 90.9% (95% CI: 88.3%-92.9%) and 72.9% (95% CI: 66.4%-78.6%), respectively. Bootstrap internal validation confirmed excellent diagnostic performance. High agreement was observed between different sample types. Conclusions: The SPINCHIP hs-cTnI POC test has very high diagnostic accuracy. Its assay-specific 0/1-hour algorithm achieved very high sensitivity/negative predictive value and specificity/positive predictive value for rule-out/in MI. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] Study [APACE]; NCT00470587).